June 30, 2016
Wing, an app-connected spirometer from St. Louis, Missouri-based Sparo Labs, is ready to take flight. The FDA recently cleared the device with an over-the-counter clearance, meaning the company can market it directly to consumers, but Sparo sees provider and pharma channels as important ones too.
With Wing, Sparo aims to help people manage asthma and other respiratory conditions, such as COPD...
April 22, 2016
Propeller Health’s connected inhaler technology helped to reduce usage of a rescue inhaler in a recent study of 495 asthma patients conducted at Dignity Health.
“The research demonstrates that the benefits of telehealth go beyond monitoring medication adherence, but can also identify patterns of risk and impairment. This additional information may allow more timely interventions and enhanced...
April 20, 2016
Australia-based ResApp, a public company, has raised $9.74 million ($12.5 million Australian dollars) for its product, a smartphone-based system for diagnosing respiratory conditions. The company sold 62.5 million new ordinary shares at $0.16 ($0.20 AU) per share.
ResApp’s offering essentially uses the smartphone microphone as a stethoscope to listen to a patient’s breathing. But instead of...
April 4, 2016
A smartphone-based system for diagnosing respiratory diseases achieved an accuracy of 89 percent in a recent clinical study of 524 pediatric patients conducted by the company at Joondalup Health Campus (JHC) and Princess Margaret Hospital (PMH) in Perth, Western Australia.
Perth-based ResApp essentially uses the smartphone microphone as a stethoscope to listen to a patient’s breathing. But...
March 21, 2016
At the same time as it announced CareKit, Apple announced in a press release that ResearchKit would be updated to more easily make use of users' genetic data, via a module designed by consumer genetics company 23andMe. Apple also added other modules for common medical tests to ResearchKit.
“The response to ResearchKit has been fantastic. Virtually overnight, many ResearchKit studies became the...
February 24, 2016
Propeller Health is partnering with Aptar Pharma, a drug delivery system company, to create what the company believes will be the first-to-market integrated, connected metered dose inhaler (MDI).
"Patients and physicians deserve better designed inhalers that are easier to use and help them successfully treat their chronic respiratory disease,” David Van Sickle, CEO of Propeller, said in a...
February 3, 2016
Louisville, Kentucky-based health insurer Humana is joining Propeller Health's Air Louisville public-private partnership. The project, launched in March 2015 in collaboration with the City of Louisville and funded by a Robert Wood Johnson Foundation grant, aims to connect sensors to 2,000 asthma inhalers and share that data, in aggregate, with city officials so it can be used to improve public...
December 3, 2015
LifeMap Solutions, the San Jose-California startup behind the ResearchKit app Asthma Health, has launched its second app, COPD Navigator, for free in the app store. At the same time, the company has launched a branded, enterprise version of COPD Navigator, called iBreathe, with chronic care management company SuperCare Health.
Both versions of the app will provide local weather and air quality...
November 3, 2015
Over the last two years, big pharma has gotten behind the idea of smartphone-connected inhalers for asthma and COPD in a big way. Two acquisitions, a $3 million investment, and a number of pilot and partnership deals have shown clearly that the space is of interest. (MobiHealthNews is helping to put on two pharma-related events at the mHealth Summit next week -- be sure to join us if you'll be in...
September 30, 2015
Adherium, the Australian connected inhaler company that partnered with AstraZeneca earlier this summer, has released data from three small studies of the company's Smartinhaler system. Data from the studies, all of which involved children and adolescents, indicate a 144 percent increase in adherence for patients using the connected devices, a 14.9 percent increase in lung function and a 37...